Trials / Terminated
TerminatedNCT05775510
Study to Evaluate Neuromodulation Subject Experience With Contemporary Spinal Cord Stimulation (SCS) Modalities for Chronic Pain
Study to Evaluate Neuromodulation Subject Experience With Contemporary Spinal Cord Stimulation (SCS) Modalities for Chronic Pain (SENSE SCS Clinical Study)
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 91 (actual)
- Sponsor
- MedtronicNeuro · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Medtronic, Inc. is sponsoring the SENSE SCS clinical study, a prospective, multi-center, post-market, non-randomized, observational study with a hybrid decentralized model of execution, utilizing a mobile application for the collection of patient reported outcomes (PROs). The purpose of the study is to evaluate workflow of a mobile application for collection of PROs and to gather data on patient experience with spinal cord stimulation therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Commercially available neurostimulation systems | Spinal cord stimulation therapy delivered during trialing and following implant of commercially available neurostimulation systems |
Timeline
- Start date
- 2023-04-25
- Primary completion
- 2025-05-29
- Completion
- 2025-05-29
- First posted
- 2023-03-20
- Last updated
- 2026-01-14
Locations
10 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05775510. Inclusion in this directory is not an endorsement.